caa a22 4500 475790812 CHVBK 20180406123710.0 cr unu---uuuuu 170329e20000401xx s 000 0 eng 10.1007/s004230050270 doi (NATIONALLICENCE)springer-10.1007/s004230050270 Duodenum-preserving pancreatic head resection in patients with benign and borderline tumors of the pancreatic head [Elektronische Daten] [M. Siech, T. Mattfeldt, W. Schlosser, H. G. Beger] Abstract : Background: Benign tumors of the pancreas are rare, accounting for only 1-2% of primary pancreatic lesions. Up to now, partial duodenopancreatectomy is still one of the established forms of treatment of benign tumors of the pancreas. We applied duodenum-preserving pancreatic head resection in 12 patients with benign pancreatic tumors to evaluate the feasibility, morbidity and recurrence rates after this less aggressive method. Methods: Between April 1984 and December 1999, 12 patients with benign and borderline tumors of the pancreatic head were operated on by duodenum-preserving pancreatic head resection. Results: All five patients with serous cystadenoma are free of recurrence 4.4 years after primary resection. One of two patients with mucinous cystadenoma and one of three patients with intraductal papillary mucinous tumor developed recurrent tumor within the former pancreatic head 5 years and 6 years, respectively, after the primary operation. Both patients were resected a second time. One of two patients with gastrinoma still has elevated serum gastrin levels. There was no hospital or long-term mortality. Conclusion: For a symptomatic serous cystadenoma, duodenum-preserving pancreatic head resection is a good alternative to partial duodenopancreatectomy. In borderline tumors with malignant potential, we would rather suggest a more radical duodenum-preserving segmental resection. A video clip (3 min) is attached demonstrating the basic steps of duodenum-preserving pancreatic head resection. Springer-Verlag Berlin Heidelberg, 2000 Key words Duodenum-preserving resection nationallicence Pancreatic head nationallicence Benign tumor nationallicence Borderline tumors nationallicence Siech M. Department of General Surgery, University of Ulm, Steinhoevelstr. 9, D-89075 Ulm, Germany Tel.: +49-731-5027233 Fax: +49-731-5027214, DE aut Mattfeldt T. Department of Pathology, University of Ulm, Germany, DE aut Schlosser W. Department of General Surgery, University of Ulm, Steinhoevelstr. 9, D-89075 Ulm, Germany Tel.: +49-731-5027233 Fax: +49-731-5027214, DE aut Beger H. G. Department of General Surgery, University of Ulm, Steinhoevelstr. 9, D-89075 Ulm, Germany Tel.: +49-731-5027233 Fax: +49-731-5027214, DE aut https://doi.org/10.1007/s004230050270 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s004230050270 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Siech M. Department of General Surgery, University of Ulm, Steinhoevelstr. 9, D-89075 Ulm, Germany Tel.: +49-731-5027233 Fax: +49-731-5027214, DE aut NATIONALLICENCE 700 1- Mattfeldt T. Department of Pathology, University of Ulm, Germany, DE aut NATIONALLICENCE 700 1- Schlosser W. Department of General Surgery, University of Ulm, Steinhoevelstr. 9, D-89075 Ulm, Germany Tel.: +49-731-5027233 Fax: +49-731-5027214, DE aut NATIONALLICENCE 700 1- Beger H. G. Department of General Surgery, University of Ulm, Steinhoevelstr. 9, D-89075 Ulm, Germany Tel.: +49-731-5027233 Fax: +49-731-5027214, DE aut Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer